Literature DB >> 33982148

Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma.

Carlos N Prieto-Granada1, Bin Xu2, Bayan Alzumaili2, Mohamed Rizwan Haroon Al Rasheed2, Antoine Eskander3, Danny Enepekides3, Snehal G Patel4, Todd M Stevens1, Snjezana Dogan2, Ronald Ghossein2, Nora Katabi5.   

Abstract

Spindle cell squamous cell carcinoma (SpC-SCC) is rare, accounting for 0.4-4% of head and neck (HN) SCCs. Better understanding of HN SpC-SCC clinicopathologic characteristics, especially features that predict outcome, is needed. We present a clinicopathologic review of 71 HN mucosal SpC-SCC from three tertiary centers. The patient population showed a median age of 63 years (range 20-91), slight male predominance (M:F = 1.6:1), and a preponderance of smokers/ex-smokers (45/71, 64%). Most lesions involved oral cavity (42/71, 59%), especially oral tongue (n = 18), and larynx (n = 20, 28%). Polypoid/exophytic growth and surface ulceration were seen in 60% and 86% of cases, respectively. Histologically, most tumors showed sarcoma-like pattern (65/70, 93%), the remaining exhibiting granulation tissue-like or fibromatosis-like patterns, and 5 lesions showed osteosarcomatous/chondrosarcomatous elements. Most tumors (53/71, 74%) showed a conventional SCC (C-SCC) component, keratinizing (86%) or non-keratinizing/basaloid (14%). Nodal metastases, seen in 22 (31%) of resection specimens, showed SpC-SCC and/or C-SCC histomorphology. By immunohistochemistry, 76% of lesions showed immunoreactivity for keratin and 62/60% of lesions were p40/p63 positive. Ki-67 proliferation index ranged from 5 to 70%. Follow-up was available on 69 patients, median of 1.1 years from the time of SpC-SCC diagnosis. The 3-, 5-, and 10-year disease-specific survival (DSS) was 62, 37, and 12%, respectively. AJCC pN stage was an independent prognostic factor for DSS and distant metastasis-free survival (DMFS), whereas the presence of C-SCC was independently associated with improved DMFS. HN SpC-SCC is rare and might be diagnostically challenging. AJCC pN stage and co-existing C-SCC component appear to be prognostically relevant.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Head and neck; Immunohistochemistry; Prognosis; Sarcomatoid carcinoma; Spindle cell squamous cell carcinoma

Mesh:

Year:  2021        PMID: 33982148      PMCID: PMC9425732          DOI: 10.1007/s00428-021-03117-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  29 in total

1.  Spindle cell carcinoma of the larynx.

Authors:  V J Hyams
Journal:  Can J Otolaryngol       Date:  1975

2.  Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Markku Miettinen; Dennis K Heffner
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

3.  Clinicopathologic Diagnostic and Prognostic Factors of Spindle Cell Carcinoma of Upper Airway.

Authors:  Amanda Bueno de Araújo; Thiago Luís Infanger Serrano; Maria Cláudia Mota Pedroso; Fernanda Viviane Mariano; Albina Altemani; Flavio Mignone Gripp; Agrício Nubiato Crespo; Carlos Takahiro Chone
Journal:  Pathol Oncol Res       Date:  2019-05-09       Impact factor: 3.201

4.  Spindle cell carcinoma of the upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma.

Authors:  Daniel Gerry; Valerie A Fritsch; Eric J Lentsch
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-08       Impact factor: 1.547

5.  Tumor Biomarkers in Spindle Cell Variant Squamous Cell Carcinoma of the Head and Neck.

Authors:  Andrew J Rosko; Andrew C Birkeland; Kevin F Wilson; Daniel G Muenz; Emily Bellile; Carol R Bradford; Jonathan B McHugh; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2016-03-15       Impact factor: 3.497

Review 6.  Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition.

Authors:  Angela Pang; Mariana Carbini; Andre L Moreira; Robert G Maki
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

7.  Outcomes and patterns of failure of sarcomatoid carcinoma of the larynx: The Mayo Clinic experience.

Authors:  Mauricio E Gamez; Elizabeth Jeans; Michael L Hinni; Eric Moore; Geoffrey Young; Daniel Ma; Lisa McGee; Matthew R Buras; Samir H Patel
Journal:  Laryngoscope       Date:  2017-07-06       Impact factor: 3.325

8.  Spindle cell carcinoma of the oral cavity and oropharynx: factors affecting outcome.

Authors:  Hsing-Hao Su; Sau-Tung Chu; Yu-Yi Hou; Kuo-Ping Chang; Chia-Jung Chen
Journal:  J Chin Med Assoc       Date:  2006-10       Impact factor: 2.743

9.  Sarcomatoid carcinoma in head and neck: a review of 30 years of experience--clinical outcomes and reconstructive results.

Authors:  Nai-Jen Chang; Dennis S Kao; Li-Yu Lee; John Wen-Cheng Chang; Ming-Mo Hou; Wee Leon Lam; Ming-Huei Cheng
Journal:  Ann Plast Surg       Date:  2013-12       Impact factor: 1.539

10.  Oncologic Outcomes of Patients With Sarcomatoid Carcinoma of the Hypopharynx.

Authors:  Liyuan Dai; Qigen Fang; Peng Li; Fei Liu; Xu Zhang
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

View more
  2 in total

Review 1.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region.

Authors:  Bin Xu
Journal:  Head Neck Pathol       Date:  2022-03-21

2.  Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation.

Authors:  Zhenhua Sun; Bingjie Xia; Ming Zhang; Shuai Xu; Yingqian Ma; Xianbo Zhang
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.